Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318306-03-000017
Filing Date
2003-11-14
Accepted
2003-11-14 17:20:03
Documents
5
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10Q r10q-511.txt 10-Q 84620
2 CERTIFICATION -CEO r10q-512.txt EX-31.1 3020
3 CERTIFICATION - CFO r10q-513.txt EX-31.2 3038
4 CERTIFICATION SO ACT - CEO r10q-514.txt EX-32.1 1685
5 CERTIFICATION SO ACT - CFO r10q-515.txt EX-32.2 1673
  Complete submission text file 0000318306-03-000017.txt   96226
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 031005997
SIC: 2834 Pharmaceutical Preparations